Resolution of Serious Vaso-occlusive Pain Crises: Results From The Ongoing Phase 1/2 HGB-206 Group C Study of Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy

被引：0

作者：

Mapara, Markus ^{[1
]}

Walters, Mark ^{[2
]}

Thompson, Alexis ^{[3
,4
]}

Kwiatkowski, Janet ^{[5
,6
]}

Krishnamurti, Lakshmanan ^{[7
]}

Aygun, Banu ^{[8
]}

Kasow, Kimberly ^{[9
]}

Rifkin-Zenenberg, Stacey ^{[10
]}

Schmidt, Manfred ^{[11
]}

Nnamani, Mauris ^{[12
]}

VanNest, Sara ^{[12
]}

Pierciey, Francis, Jr. ^{[12
]}

Miller, Alex ^{[12
]}

Chen, Ren ^{[12
]}

Kim, Dennis ^{[12
]}

Goyal, Sunita ^{[12
]}

Kanter, Julie ^{[13
]}

Tisdale, John ^{[14
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA

[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[4] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA

[5] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[6] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[7] Emory Univ, Childrens Healthcare Atlanta, Atlanta, GA 30322 USA

[8] Cohen Childrens Med Ctr, Queens, NY USA

[9] Univ N Carolina, Chapel Hill, NC 27515 USA

[10] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[11] GeneWerk GmbH, Heidelberg, Germany

[12] Bluebird Bio Inc, Cambridge, MA USA

[13] Univ Alabama Birmingham, Birmingham, AL USA

[14] NIH, Bldg 10, Bethesda, MD 20892 USA

来源：

BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O056

引用

页码：66 / 68

页数：3

共 42 条

[31] Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises
Gupta, Ashish O.
Sharma, Akshay
Frangoul, Haydar
Dalal, Jignesh
Kanter, Julie
Alavi, Asif
Dipersio, John
Eapen, Mary
Jaroscak, Jennifer J.
Ayala, Ernesto
Ziga, Edward D.
Rifkin-Zenenberg, Stacey
Minella, Alex C.
Chen, Guo
Chen, Yinzhong
Chockalingam, Priya S.
Lin, Ling
Joseney-Antoine, Marcelyne
Ianniello, Leanne
Gardner, Beth
Hartigan, Adam J.
Ciaramella, Giuseppe
Goyal, Sunita
Simon, Amy
Thompson, Alexis
Heeney, Matthew M.
[J]. BLOOD, 2024, 144 : 514 - 515
[32] GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease
Telen, Marilyn J.
Wun, Ted
McCavit, Timothy L.
De Castro, Laura M.
Krishnamurti, Lakshmanan
Lanzkron, Sophie
Hsu, Lewis L.
Smith, Wally R.
Rhee, Seungshin
Magnani, John L.
Thackray, Helen
[J]. BLOOD, 2013, 122 (21)
[33] Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+HSPCs for Sickle Cell Disease (SCD)
Alavi, Asif
Krishnamurti, Lakshmanan
Abedi, Mehrdad
Galeon, Isobelle
Reiner, David
Smith, Sharon E.
Wang, Lin
Ramezi, Anne
Rendo, Pablo
Walters, Mark C.
[J]. BLOOD, 2021, 138
[34] Early Results from a Phase 1/2 Study of ARU-1801 Gene Therapy for Sickle Cell Disease (SCD): Safety and Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant
Grimley, Michael
Asnani, Monika
Shrestha, Archana
Felker, Sydney
Lutzko, Carolyn
Arumugam, Paritha I.
Witting, Scott
Knight-Madden, Jennifer
Niss, Omar
Quinn, Charles T.
Lo, Christopher
Little, Courtney R.
McIntosh, Joseph W.
Malik, Punam
[J]. MOLECULAR THERAPY, 2021, 29 (04) : 39 - 40
[35] Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease
Salvino, Marco Aurelio
Antmen, Bulent
Asirwa, Frederick Chite
Chonat, Satheesh
De Franceschi, Lucia
Eleftheriou, Perla
Inati, Adlette
Mahlangu, Johnny
Nur, Erfan
Payan-Pernia, Salvador
Charania, Asad
Gradinaru, Diana
Hsia, Allison
Luder, Yves
Perretti, Thomas
Srekovic, Sasha
Bartolucci, Pablo
[J]. BLOOD, 2023, 142
[36] Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
Hopkin, Robert J.
Ganesh, Jaya
Bernat, John
Goker-Alpan, Ozlem
Nicholls, Kathleen
Pahl, Madeleine V.
Deegan, Patrick B.
Whitley, Chester B.
Hughes, Derralynn
Cao, Liching
Chen, Michael
Shiue, Lisa
Rojkjaer, Lisa
Wilcox, William R.
[J]. MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[37] Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
Hughes, Derralynn
Wilcox, William
Hopkin, Robert J.
Ganesh, Jaya
Bernat, John
Goker-Alpan, Ozlem
Nicholls, Kathy
Deegan, Patrick
Pahl, Madeleine
Whitley, Chester B.
Chen, Michael
Cao, Liching
Schreeb, Katharina H.
[J]. MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02)
[38] Early Results from a Phase 1/2 Study of Aru-1801 Gene Therapy for Sickle Cell Disease (SCD): Manufacturing Process Enhancements Improve Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant
Grimley, Michael
Asnani, Monika
Shrestha, Archana
Felker, Sydney
Lutzko, Carolyn
Arumugam, Paritha I.
Witting, Scott
Knight-Madden, Jennifer
Niss, Omar
Quinn, Charles T.
Lo, Chris
Little, Courtney R.
McIntosh, Joseph W.
Malik, Punam
[J]. BLOOD, 2020, 136
[39] Safety and Efficacy of Aru-1801 in Patients with Sickle Cell Disease: Early Results from the Phase 1/2 Momentum Study of a Modified Gamma Globin Gene Therapy and Reduced Intensity Conditioning
Grimley, Michael
Asnani, Monika
Shrestha, Archana
Felker, Sydney
Lutzko, Carolyn
Arumugam, Paritha I.
Witting, Scott
Knight-Madden, Jennifer
Niss, Omar
Quinn, Charles T.
Lo, Chris
Little, Courtney R.
Dong, Alisa
Malik, Punam
[J]. BLOOD, 2021, 138
[40] Initial Results from the Northstar Study (HGB-204): A Phase 1/2 Study of Gene Therapy for β-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral βA-T87Q Globin Vector (LentiGlobin BB305 Drug Product)
Thompson, Alexis A.
Rasko, John E.
Hongeng, Suradej
Kwiatkowski, Janet L.
Schiller, Gary
von Kalle, Christof
Cavazzana, Marina
Leboulch, Philippe
Petrusich, Alexandria
Soni, Sandeep
Walters, Mark C.
[J]. BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →